By IDSE News Staff
The FDA approved tecovirimat (TPOXX, SIGA Technologies), the first drug indicated to treat smallpox in the event of a biological attack.
Although the World Health Organization declared smallpox—a contagious and sometimes fatal infectious disease—eradicated in 1980, there have been long-standing concerns that smallpox could be used as a bioweapon, according to a statement from the FDA.
“To address the risk of bioterrorism, Congress has taken steps to